This year’s Pediatric Year in Review will highlight the most recent developments in four areas of pediatric pulmonary medicine: cystic fibrosis, asthma, primary ciliary dyskinesia and bronchiectasis, and neuromuscular disorders.

The Sunday, May 19, session will take place at 2:15 p.m. PT in Room 6B (Upper Level) of the San Diego Convention Center.

A panel of pediatric pulmonary experts will review some of the most recent literature and current issues in pediatric respiratory disease. Attendees will learn about the role of “omics” technologies and personalized medicine in improving clinical outcomes in pediatric patients with respiratory disease, as well as the impact of access to care and medication costs on patient outcomes and health disparities.

• Meghan E. McGarry, MD, University of California, San Francisco, will provide an update on cystic fibrosis modulators and beyond.
• Theresa W. Guilbert, MD, MS, Cincinnati Children’s Hospital, will address omics and biologics and their role in precision medicine in asthma.
• Caroline Okorie, MD, MPH, Stanford University, will discuss the management of neuromuscular disorders in children.
• Jessica E. Pittman, MD, MPH, Washington University School of Medicine, will talk about primary ciliary dyskinesia and non-CF bronchiectasis.

Erik Forno, MD, MPH, ATSF, Riley Children’s Hospital Indiana University, and Deepa Tastogi, MBBS, MS, ATSF, Children’s Hospital at Montefiore, Albert Einstein College of Medicine, will co-chair the session.

This session and the International Conference are supported by an independent medical educational grant from Chiesi USA, Inc., Vertex Pharmaceuticals, Inc., and Insmed Incorporated. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests).